Viewing Study NCT05665361


Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2026-01-12 @ 2:24 PM
Study NCT ID: NCT05665361
Status: RECRUITING
Last Update Posted: 2025-10-27
First Post: 2022-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module